ATR-101, a Selective and Potent Inhibitor of Acyl-CoA Acyltransferase 1, Induces Apoptosis in H295R Adrenocortical Cells and in the Adrenal Cortex of Dogs
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
ATR-101 is a novel, oral drug candidate currently in development for the treatment of adrenocortical cancer. ATR-101 is a selective and potent inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1), an enzyme located in the endoplasmic reticulum (ER) membrane that catalyzes esterification of intracellular free cholesterol (FC). We aimed to identify mechanisms by which ATR-101 induces adrenocortical cell death. In H295R human adrenocortical carcinoma cells, ATR-101 decreases the formation of cholesteryl esters and increases FC levels, demonstrating potent inhibition of ACAT1 activity. Caspase-3/7 levels and terminal deoxynucleotidyl transferase 2′-deoxyuridine 5′-triphosphate nick end labeled-positive cells are increased by ATR-101 treatment, indicating activation of apoptosis. Exogenous cholesterol markedly potentiates the activity of ATR-101, suggesting that excess FC that cannot be adequately esterified increases caspase-3/7 activation and subsequent cell death. Inhibition of calcium release from the ER or the subsequent uptake of calcium by mitochondria reverses apoptosis induced by ATR-101. ATR-101 also activates multiple components of the unfolded protein response, an indicator of ER stress. Targeted knockdown of ACAT1 in an adrenocortical cell line mimicked the effects of ATR-101, suggesting that ACAT1 mediates the cytotoxic effects of ATR-101. Finally, in vivo treatment of dogs with ATR-101 decreased adrenocortical steroid production and induced cellular apoptosis that was restricted to the adrenal cortex. Together, these studies demonstrate that inhibition of ACAT1 by ATR-101 increases FC, resulting in dysregulation of ER calcium stores that result in ER stress, the unfolded protein response, and ultimately apoptosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ACAT1 is an enzyme that converts free cholesterol to cholesterol esters for storage, and ACAT1 inhibition impairs all adrenocortical steroidogenesis125.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [125]
Citations
Cites
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., & Mori, K. (2001) · Cell · doi:10.1016/s0092-8674(01)00611-0 · Cited by 4,039
IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA
Calfon, M., Zeng, H., Urano, F., Till, J. H., Hubbard, S. R., Harding, H. P., Clark, S. G., & Ron, D. (2002) · Nature · doi:10.1038/415092a · Cited by 2,820
Travers, K. J., Patil, C. K., Wodicka, L., Lockhart, D. J., Weissman, J. S., & Walter, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80835-1 · Cited by 1,992
The mitochondrial calcium uniporter is a highly selective ion channel
Kirichok, Y., Krapivinsky, G., & Clapham, D. E. (2004) · Nature · doi:10.1038/nature02246 · Cited by 1,409
Role of cholesterol and lipid organization in disease
Maxfield, F. R., & Tabas, I. (2005) · Nature · doi:10.1038/nature04399 · Cited by 1,293
Caspases 3 and 7: Key Mediators of Mitochondrial Events of Apoptosis
Lakhani, S. A., Masud, A., Kuida, K., Porter, G. A., Booth, C. J., Mehal, W. Z., Inayat, I., & Flavell, R. A. (2006) · Science · doi:10.1126/science.1115035 · Cited by 1,178
Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis
Lin, D., Sugawara, T., Strauss, J. F., Clark, B. J., Stocco, D. M., Saenger, P., Rogol, A., & Miller, W. L. (1995) · Science · doi:10.1126/science.7892608 · Cited by 1,030 · cited 1×
“mon and requisite precursor, cholesterol (1).”
Maruyama, T., Kanaji, T., Nakade, S., Kanno, T., & Mikoshiba, K. (1997) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021780 · Cited by 904
The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages
Feng, B., Yao, P. M., Li, Y., Devlin, C. M., Zhang, D., Harding, H. P., Sweeney, M., Rong, J. X., Kuriakose, G., Fisher, E. A., et al. (2003) · Nature Cell Biology · doi:10.1038/ncb1035 · Cited by 885
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Lipid metabolism reprogramming and its potential targets in cancer
Cheng, C., Geng, F., Cheng, X., & Guo, D. (2018) · Cancer Communications · doi:10.1186/s40880-018-0301-4 · Cited by 850
Advances in the medical treatment of Cushing's syndrome
Feelders, R. A., Newell-Price, J., Pivonello, R., Nieman, L. K., Hofland, L. J., & Lacroix, A. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30155-4 · Cited by 154
Adrenocortical carcinoma — towards genomics guided clinical care
Crona, J., & Beuschlein, F. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0221-7 · Cited by 159
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
Pivonello, R., Ferrigno, R., Martino, M. C. D., Simeoli, C., Paola, N. D., Pivonello, C., Barba, L., Negri, M., de Angelis, C., & Colao, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00648 · Cited by 147
The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives
Wang, W., Bai, L., Li, W., & Cui, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.605154 · Cited by 126
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Hoppstädter, J., Dembek, A., Höring, M., Schymik, H. S., Dahlem, C., Sultan, A., Wirth, N., Al-Fityan, S., Diesel, B., Gasparoni, G., et al. (2021) · eBioMedicine · doi:10.1016/j.ebiom.2021.103578 · Cited by 99
Next-generation therapies for adrenocortical carcinoma
Altieri, B., Ronchi, C. L., Kroiß, M., & Faßnacht, M. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101434 · Cited by 110
Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy
Qiao, X., Hu, Z., Xiong, F., Yang, Y., Peng, C., Wang, D., & Li, X. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01807-1 · Cited by 103
Structure of nevanimibe-bound tetrameric human ACAT1
Long, T., Sun, Y., Hassan, A., Qi, X., & Li, X. (2020) · Nature · doi:10.1038/s41586-020-2295-8 · Cited by 97
Qi, X., Li, Q., Che, X., Wang, Q., & Wu, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.727778 · Cited by 97
Treating canine Cushing’s syndrome: Current options and future prospects
Sanders, K., Kooistra, H. S., & Galac, S. (2018) · The Veterinary Journal · doi:10.1016/j.tvjl.2018.09.014 · Cited by 85
Pharmacological profile and effects of mitotane in adrenocortical carcinoma
Corso, C. R., Acco, A., Bach, C., Bonatto, S. J. R., de Figueiredo, B. C., & de Souza, L. M. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14721 · Cited by 74
Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions
Kaiser, C. M. F., Romano, P. S., Vanrell, M. C., Pocognoni, C. A., Jacob, J., Caruso, B., & Delgui, L. R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.826248 · Cited by 71
Smith, D. C., Kroiß, M., Kebebew, E., Habra, M. A., Chugh, R. K., Schneider, B. J., Faßnacht, M., Jafarinasabian, P., Ijzerman, M. M., Lin, V. H., et al. (2020) · Investigational New Drugs · doi:10.1007/s10637-020-00899-1 · Cited by 71
Antitumor effects of curcumin: A lipid perspective
Naeini, M. B., Momtazi‐Borojeni, A. A., Jaafari, M. R., Johnston, T. P., Barreto, G. E., Banach, M., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28262 · Cited by 60
Xiao, L., Wang, Q., & Peng, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1157291 · Cited by 59
Ayyagari, V. N., Wang, X., Díaz‐Sylvester, P., Groesch, K. A., & Brard, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228024 · Cited by 59
Theoretical framework and emerging challenges of lipid metabolism in cancer
Gu, Q., Wang, Y., Yi, P., & Cheng, C. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.12.002 · Cited by 52
Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era
Mohan, D. R., Lerário, A. M., & Hammer, G. D. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00197 · Cited by 46
Self-citationUpdate on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies
Lerário, A. M., Mohan, D. R., & Hammer, G. D. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac012 · Cited by 41
Self-citationCurrent and Novel Treatment Strategies in Children with Congenital Adrenal Hyperplasia
Nordenström, A., Falhammar, H., & Lajić, S. (2022) · Hormone Research in Paediatrics · doi:10.1159/000522260 · Cited by 41
Advances in translational research of the rare cancer type adrenocortical carcinoma
Ghosh, C., Hu, J., & Kebebew, E. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00623-0 · Cited by 40
The ER-mitochondria couple: In life and death from steroidogenesis to tumorigenesis
Doghman, M., & Lalli, E. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.050 · Cited by 40
Ruggiero, C., Doghman, M., Ronco, C., Benhida, R., Rocchi, S., & Lalli, E. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.02.010 · Cited by 37
Bhattacharjee, P., Rutland, N., & Iyer, M. R. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01265 · Cited by 36
Chukkalore, D., MacDougall, K. N., Master, V. A., Bilen, M. A., & Nazha, B. (2024) · The Oncologist · doi:10.1093/oncolo/oyae029 · Cited by 35
Role of Lipoproteins in the Microenvironment of Hormone-Dependent Cancers
Gomaraschi, M. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.11.005 · Cited by 35
A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia
El-Maouche, D., Merke, D. P., Vogiatzi, M. G., Chang, A. Y., Turcu, A. F., Joyal, E. G., Lin, V. H., Weintraub, L., Plaunt, M. R., Mohideen, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa381 · Cited by 34
Novel treatments for congenital adrenal hyperplasia
Schröder, M. A. M., & der Grinten, H. L. C. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09717-w · Cited by 35
Feng, X., Zhang, J., Yu, B., An, W., & Jin, X. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104881 · Cited by 32
Weigand, I., Altieri, B., Lacombe, A. M. F., Basile, V., Kircher, S., Landwehr, L., Schreiner, J., Zerbini, M. C. N., Ronchi, C. L., Megerle, F., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa293 · Cited by 33
Kurlbaum, M., Sbiera, S., Kendl, S., Fassnacht, M. M., & Kroiß, M. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1105-6332 · Cited by 32
Wang, K., Lee, C., Sui, X., Kim, S., Wang, S., Higgs, A., Baublis, A., Voth, G. A., Liao, M., Walther, T. C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38932-5 · Cited by 31
Eckhardt, C., Sbiera, I., Krebs, M., Sbiera, S., Spahn, M., Kneitz, B., Joniau, S., Faßnacht, M., Kübler, H. R., Weigand, I., et al. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00431-3 · Cited by 30
MANAGEMENT OF ENDOCRINE DISEASE: Can we cure Cushing’s disease? A personal view
BERTAGNA, X. Y. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0062 · Cited by 27
Gómez‐Coronado, D., Lasunción, M. A., Martínez-Botas, J., & Fernández‐Suárez, M. E. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.08.015 · Cited by 26
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
Wing, P. A. C., Schmidt, N. M., Peters, R., Erdmann, M., Brown, R. L., Wang, H., Swadling, L., COVIDsortium Investigators, Newman, J., Thakur, N., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011323 · Cited by 26
Langlois, D. K., Fritz, M. C., Schall, W. D., Olivier, N. B., Smedley, R. C., Pearson, P. G., Bailie, M. B., & Hunt, S. W. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0251-5 · Cited by 24
Self-citationKnott, E. L., & Leidenheimer, N. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228485 · Cited by 24
Rocking the MBOAT: Structural insights into the membrane bound O-acyltransferase family
Coupland, C. E., Ansell, T. B., Sansom, M. S. P., & Siebold, C. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102589 · Cited by 22
Burns, V. E., & Kerppola, T. K. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13951 · Cited by 20
Liver X receptor inhibition potentiates mitotane-induced adrenotoxicity in ACC
Warde, K. M., Schoenmakers, E., Martínez, E. R., Lim, Y. J., Leonard, M., Lawless, S. J., O’Shea, P. M., Chatterjee, K., Gurnell, M., Hantel, C., et al. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0031 · Cited by 19
Chiu, Y.-C., Chu, P.-W., Lin, H.-C., & Chen, S.-K. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101166 · Cited by 18
Generation and characterization of a mitotane-resistant adrenocortical cell line
Seidel, E., Walenda, G., Messerschmidt, C., Obermayer, B., Peitzsch, M., Wallace, P. W., Bahethi, R., Yoo, T., Choi, M., Schrade, P., et al. (2020) · Endocrine Connections · doi:10.1530/ec-19-0510 · Cited by 18
Emerging medical therapies for congenital adrenal hyperplasia
Speiser, P. (2019) · F1000Research · doi:10.12688/f1000research.17778.1 · Cited by 17
Boulate, G., Amazit, L., Naman, A., Seck, A., Paci, A., Lombès, A., Pussard, E., Baudin, É., Lombès, M., & Hescot, S. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4770 · Cited by 17
Nocito, M. C., Hantel, C., Lerário, A. M., Mastrorocco, F., Martino, L. D., Musicco, C., Perrotta, I. D., Scalise, M., Indiveri, C., Giannattasio, S., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07607-y · Cited by 16
Mogol, A. N., Zuo, Q., Yoo, J. Y., Kaminsky, A. Z., Imir, O. B., Landesman, Y., Walker, C. J., & Madak‐Erdogan, Z. (2023) · Endocrinology · doi:10.1210/endocr/bqad073 · Cited by 16
A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma
Flauto, F., Martino, M. C. D., Vitiello, C., Pivonello, R., Colao, A., & Damiano, V. (2024) · Cancers · doi:10.3390/cancers16234061 · Cited by 13
Mitotane Targets Lipid Droplets to Induce Lipolysis in Adrenocortical Carcinoma
Warde, K. M., Lim, Y. J., Martínez, E. R., Beuschlein, F., O’Shea, P. M., Hantel, C., & Dennedy, M. C. (2022) · Endocrinology · doi:10.1210/endocr/bqac102 · Cited by 13
Websdale, A., Kiew, Y., Chalmers, P., Chen, X., Cioccoloni, G., Hughes, T. A., Luo, X., Mwarzi, R., Poirot, M., Røberg‐Larsen, H., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114731 · Cited by 12
New strategies for applying targeted therapies to adrenocortical carcinoma
Mohan, D. R., Lerário, A. M., Finco, I., & Hammer, G. D. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.07.006 · Cited by 12
Self-citationWang, Y., Yu, W., Wang, X., Zhao, Q., Lei, Q., Li, A., Liu, S., Wang, T., Yang, L., & Zhang, Y. (2025) · Advanced Science · doi:10.1002/advs.202506995 · Cited by 11
Torre, A. L. D. L., Huynh, T. N. T., Chang, C. C. Y., Pooler, D. B., Ness, D. B., Lewis, L. D., Pannem, S., Feng, Y., Samkoe, K. S., Hickey, W. F., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311013 · Cited by 11
Sun, J., Huai, J., Zhang, W., Zhao, T., Run, S., Wang, X., Li, M., Jiao, X., & Zhou, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1545012 · Cited by 10
Martino, M., Aboud, N., Lucchetti, B., Salvio, G., & Arnaldi, G. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2192349 · Cited by 10
Systemic Management of Advanced Adrenocortical Carcinoma
Russell, J. S. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01249-6 · Cited by 9
Is Lipid Metabolism of Value in Cancer Research and Treatment? Part I- Lipid Metabolism in Cancer
Nassar, A. F., Nie, X., Zhang, T., Yeung, J. T., Norris, P. C., He, J., Ogura, H., Babar, M. U., Muldoon, A., Libreros, S., et al. (2024) · Metabolites · doi:10.3390/metabo14060312 · Cited by 8
Therapeutic compounds for Cushing’s syndrome: a patent review (2012-2016)
Ma, L., Yin, L., & Hu, Q. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1217331 · Cited by 8
Detomas, M., Deutschbein, T., & Altieri, B. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2317-0801 · Cited by 7
Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 Mutations
Maki, R., Iwagami, Y., Kobayashi, S., Sasaki, K., Yamada, D., Tomimaru, Y., Sakai, D., Noda, T., Asaoka, T., Takahashi, H., et al. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17482-8 · Cited by 7
Mao, S., Zhou, W., Cheng, A., Cao, H., & Bei, Y. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106820 · Cited by 6
Regulation of lipid droplets and cholesterol metabolism in adrenal cortical cells
Dalen, K. T., & Li, Y. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.06.007 · Cited by 5
Kroiß, M., & Faßnacht, M. (2016) · Endocrinology · doi:10.1210/en.2016-1210 · Cited by 5
Hill, J. R., Shao, X., Wright, J. S., Stauff, J., Sherman, P. S., Arteaga, J., Wong, K. K., Viglianti, B. L., Scott, P. J. H., & Brooks, A. F. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00127 · Cited by 5
Current and Emerging Pharmacological Therapies for Cushing's Disease
Divaris, E., Kostopoulos, G., & Efstathiadou, Z. A. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128290025240216110928 · Cited by 3
Regulation of Adrenal Steroidogenesis
Pihlajoki, M., Heikinheimo, M., & Wilson, D. B. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_2 · Cited by 4
Current Status and Future Direction in the Treatment of Advanced Adrenocortical Carcinoma
Pak, C., Yoon, S., Lee, J., Yun, T., & Park, I. (2024) · Current Oncology Reports · doi:10.1007/s11912-024-01510-z · Cited by 2
To, H., Reinholdt, P., Bashawat, M., Luck, M., Lauritsen, L., Akkerman, V., Kroiß, M., Wüstner, D., Kongsted, J., Müller, P. K., et al. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112385 · Cited by 2
Targeting of a New Node in Lipid Metabolism as a Potential Treatment Strategy for ACC
LaPensee, C. R., & Hammer, G. D. (2023) · Endocrinology · doi:10.1210/endocr/bqad003 · Cited by 2
Self-citationLerário, A. M., & Hammer, G. D. (2018) · Oncotarget · doi:10.18632/oncotarget.26091 · Cited by 2
Self-citationNew targeted therapies for adrenocortical carcinomas
Manso, J., & Pezzani, R. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02860-2 · Cited by 2
Pharmacologic Alteration of Meibum Lipid Composition Alleviates Dry Eye Phenotype in Awat2 −/− Mice
Widjaja‐Adhi, M. A. K., Chung, C., Lapierre-Landry, M., Chao, K., Lu, E. Y., Swigris, J., Walczak, A., Golczak, W., Sayegh, R. R., Jenkins, M. W., et al. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.6.34 · Cited by 1
Are Cushing's disease patients curable?
BERTAGNA, X. Y. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.012 · Cited by 1
Biochemical mechanism of the o,p’-DDD effect on the adrenal cortex
As, M., & Ковзун, О. І. (2017) · The Ukrainian Biochemical Journal · doi:10.15407/ubj89.05.005 · Cited by 1
Therapies for Locally Advanced and Metastatic Adrenocortical Carcinoma
Rao, S. N., & Habra, M. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_14
van Staalduinen, G. J. (2018) · Utrecht University Repository (Utrecht University)
Зелінська, Н. Б. (2019) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy
Adrenal Gq Signaling: Implications for Maintenance of Zonation and Steroidogenesis
Taylor, M. J. (2019) · Deep Blue (University of Michigan)
Eckhardt, C. (2021) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-24300
Kurlbaum, M., Sbiera, S., Kendl, S., Faßnacht, M., & Kroiß, M. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1169-5951
Mohan, D. R. (2021) · Deep Blue (University of Michigan) · doi:10.7302/7242
Serrano-Recalde, E. C. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Blanco, J., Martín, H., & Martín-Gómez, L. (2026) · Aquatic Toxicology · doi:10.1016/j.aquatox.2026.107814
Agarwal, S., Popert, R., Agapow, P., Ruff, C. A., & Gupta, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.21.727002
Xu, X.-X., ZHOU, G., Du, C.-Z., Gao, X., Guo, X.-W., Li, Y. D., Lu, M.-Y., He, T.-X., Chen, P., & Li, H. B. (2026) · Discover Oncology · doi:10.1007/s12672-026-05500-4
Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia
Goai, W. H., & Torpy, D. J. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2695099
BindingDB Entry 50018685: Targeting Sterol
BindingDB (2024) · UC San Diego · doi:10.7270/q2s46x68
Metadata
- Authors
- LaPensee, C. R., Mann, J. E., Rainey, W. E., Crudo, V., Hunt, S. W., & Hammer, G. D.
- Affiliations
- University of Michigan (US)
- Atterocor, Inc (S.W.H.), Ann Arbor, Michigan 48104
- Corresponding author
- Hammer, Gary D.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2016-03-17
- Volume
- 157
- Issue
- 5
- Pages
- 1775-1788
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2297410578
- Cited by
- 86
- References
- 56
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 9 · 2023: 12 · 2022: 8 · 2021: 5 · 2020: 15 · 2019: 7 · 2018: 11 · 2017: 3 · 2016: 5
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- adrenocortical carcinoma, apoptosis, free cholesterol, endoplasmic reticulum stress, unfolded protein response, caspase-3/7 activation, endoplasmic reticulum calcium release, mitochondrial calcium uptake, adrenal cortex, dogs, H295R cells
- MeSH terms
- Adrenal Cortex, Adrenal Cortex Neoplasms, Animals, Sterol O-Acyltransferase, Dogs, Humans, Phenylurea Compounds, Apoptosis, Adrenocortical Carcinoma, Cell Line, Tumor, Membrane Potential, Mitochondrial, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.